The Merck Healthcare Business to Keynote Veeva R&D Summit Europe
Veeva Systems (NYSE:VEEV) will host the 2019 Veeva R&D Summit, Europe from June 11-13 in Barcelona, bringing together the world’s most innovative life sciences companies. The fourth annual event will feature more than 30 speakers from leading global pharmaceutical companies and emerging biotechs, including AstraZeneca, Bayer, Horizon, and UCB. Keynotes and breakout sessions will showcase the latest advancements in unifying systems and processes in clinical, regulatory, and quality for faster product development.
Dr. Jacques Mascaro, senior vice president and head of regulatory affairs and R&D quality at the Healthcare business of the Merck Group, is the featured keynote speaker at this year’s event. He will share Merck Healthcare’s vision to streamline drug development processes with unified and connected suites of applications across research and development.
This year’s agenda also features 28 sessions on optimizing trial performance, modernizing quality management, and transforming regulatory operations, including:
- AstraZeneca sharing best practices for modernizing clinical operations and streamlining trial execution with a unified suite of applications.
- Novo Nordisk explaining how they modernized and simplified a fragmented system landscape for controlled content management - eliminating IT risks and gaining greater business value.
- GE Healthcare discussing lessons learned in regulatory transformation, from improving the planning process to streamlining cross-functional business processes and measuring success.
2019 Veeva R&D Summit, Europe is sponsored by Accenture, Deloitte, NNIT, Valiance, CGI, Eagle Productivity Solutions, fme AG, PwC Germany, SDL, BASE life science, Epista Life Sciences, Ideagen, INCONSULT, Kinapse, and LPW Training.
The event is open to Veeva customers and invited guests. Learn more, register, and view the agenda at veeva.com/EUSummit .
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 700 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com/eu .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CA-ANDERSEN-TAX23.5.2019 22:49:12 CEST | Pressemeddelelse
Andersen Global udvider lokaliteter i Storbritannien
VA-CTA23.5.2019 22:02:10 CEST | Pressemeddelelse
Audi China President Thomas Owsianski to Keynote at CES Asia 2019
VA-ITECHLAW23.5.2019 21:13:07 CEST | Pressemeddelelse
ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence
KUMULUS-VAPE23.5.2019 18:51:10 CEST | Pressemeddelelse
Kumulus Vape, the 100% Online E-Cigarette Specialist, Goes Public
MINDBREEZE23.5.2019 15:13:11 CEST | Pressemeddelelse
Mindbreeze Receives Attestation in Accordance with BSI Cloud Requirements
BACARDI-LIMITED23.5.2019 14:17:06 CEST | Pressemeddelelse
Bacardi Limited Announces 5th Annual Good Spirited Awards for Employee-Led Global Environmental Sustainability Programs
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum